ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $659,275 | +34.6% | 1,341 | +6.7% | 0.00% | – |
| Q2 2023 | $489,890 | +22.7% | 1,257 | +17.3% | 0.00% | – |
| Q1 2023 | $399,405 | -5.3% | 1,072 | -3.7% | 0.00% | – |
| Q4 2022 | $421,639 | +7.8% | 1,113 | +0.6% | 0.00% | – |
| Q3 2022 | $391,000 | +12.0% | 1,106 | +20.1% | 0.00% | – |
| Q2 2022 | $349,000 | +59.4% | 921 | +32.9% | 0.00% | – |
| Q1 2022 | $219,000 | +87.2% | 693 | +105.6% | 0.00% | – |
| Q4 2021 | $117,000 | -0.8% | 337 | -14.5% | 0.00% | – |
| Q3 2021 | $118,000 | +15.7% | 394 | +16.2% | 0.00% | – |
| Q2 2021 | $102,000 | +72.9% | 339 | +59.9% | 0.00% | – |
| Q1 2021 | $59,000 | +59.5% | 212 | +69.6% | 0.00% | – |
| Q4 2020 | $37,000 | +3600.0% | 125 | +4066.7% | 0.00% | – |
| Q3 2020 | $1,000 | -87.5% | 3 | -94.7% | 0.00% | – |
| Q2 2019 | $8,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |